A new study demonstrates the potential for use of Dune Medical’s MarginProbe system in surgical margin assessment during radical prostatectomy procedures.
St. James’s University Hospital, Leeds, UK, harnesses Elekta’s Agility multileaf collimator (MLC) and Elekta VMAT to treat patient with tongue cancer
Swedish medtech company, SciBase, has announced positive results from its pivotal study of Nevisense, a unique non-invasive point-of-care device for detection of Malignant Melanoma.
Cleveland medical device company ViewRay Inc., has received U.S. FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features what the company calls a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer.
Cook’s range of fine needle biopsy histology needles is enhanced by the addition of this new 25gauge iteration, which, according to the company, is the smallest gauge endoscopy needle available today.
Let’s not argue about how to spell gauge by the way.
Covidien has unveiled its new range add HALO 90 ULTRA for ablative treatment of large Barrett’s Oesophagus lesions. The device, which comes from the stable of recently acquired Barrx Medical, is double the length of its HALO 90 brother and as such can reduce ablation treatment time and in so doing shorten the procedure.
Top universities really do churn out some brilliant work. In this case Stanford researchers have published on the use of coated gold nanoparticles which selectively find cancer cells and aid in their isolation for treatment, potentially improving accuracy with the benefit of minimising collateral damage and ensuring no cancer remains.
Expensive Proton Beam therapy availability is limited this side of the pond. For once we don’t advocate speeding adoption, but a lack of evidence doesn’t seem to have slowed demand for its use as a prostate treatment in USA.
AngioDynamics has completed patient enrollment in its European prospective NanoKnife® System trial for the treatment of locally advanced unresectable pancreatic cancer.
Vascular Designs, Inc.has announced that its IsoFlow™ Infusion Catheter has received CE Mark approval for use in Europe and Canada
Latest findings, presented at the NCRI Cancer Conference in Liverpool, UK, highlight the positive impact that the NICE referral guideline for suspected cancer has had since its launch in 2005.
Advanced multi modality system takes its place in new £100 million Cancer Care facility due to open in Spring 2012